Mesa Laboratories, Inc. Stock

Equities

MLAB

US59064R1095

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-22 pm EDT 5-day change 1st Jan Change
102.3 USD +1.51% Intraday chart for Mesa Laboratories, Inc. -2.10% -2.40%
Sales 2024 * 212M Sales 2025 * 235M Capitalization 552M
Net income 2024 * - Net income 2025 * 2M EV / Sales 2024 * 2.61 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 2.35 x
P/E ratio 2024 *
-1,859 x
P/E ratio 2025 *
273 x
Employees 698
Yield 2024 *
0.63%
Yield 2025 *
0.63%
Free-Float 94.26%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.51%
1 week-2.10%
Current month-6.81%
1 month-0.73%
3 months+6.09%
6 months+5.90%
Current year-2.40%
More quotes
1 week
98.91
Extreme 98.91
104.35
1 month
97.75
Extreme 97.75
112.55
Current year
88.65
Extreme 88.65
115.75
1 year
82.86
Extreme 82.86
178.64
3 years
82.86
Extreme 82.86
333.42
5 years
82.86
Extreme 82.86
333.42
10 years
54.60
Extreme 54.598
333.42
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 17-03-19
Chairman 71 04-09-30
Director of Finance/CFO 55 12-10-28
Members of the board TitleAgeSince
Chairman 71 04-09-30
Director/Board Member 61 Jan. 04
Director/Board Member 65 22-06-22
More insiders
Date Price Change Volume
24-04-22 102.3 +1.51% 36,134
24-04-19 100.7 +1.12% 27,080
24-04-18 99.62 -1.50% 31,078
24-04-17 101.1 -1.33% 30,554
24-04-16 102.5 -1.87% 26,434

Delayed Quote Nasdaq, April 22, 2024 at 04:00 pm EDT

More quotes
Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
102.3 USD
Average target price
130 USD
Spread / Average Target
+27.13%
Consensus